PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $259,597 | +9.0% | 6,383 | +29.8% | 0.00% | 0.0% |
| Q1 2023 | $238,131 | -5.5% | 4,916 | -7.8% | 0.00% | 0.0% |
| Q1 2021 | $252,000 | -34.7% | 5,332 | -15.7% | 0.00% | -50.0% |
| Q4 2020 | $386,000 | -48.2% | 6,327 | -60.3% | 0.00% | -33.3% |
| Q3 2020 | $745,000 | -25.1% | 15,935 | -18.7% | 0.00% | -40.0% |
| Q2 2020 | $995,000 | +19.0% | 19,602 | +4.7% | 0.01% | 0.0% |
| Q1 2020 | $836,000 | +195.4% | 18,730 | +217.6% | 0.01% | +400.0% |
| Q4 2019 | $283,000 | +10.1% | 5,897 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $257,000 | -15.2% | 5,703 | -35.4% | 0.00% | -50.0% |
| Q4 2018 | $303,000 | -32.1% | 8,823 | -7.1% | 0.00% | 0.0% |
| Q3 2018 | $446,000 | +94.8% | 9,493 | -17.2% | 0.00% | +100.0% |
| Q3 2017 | $229,000 | – | 11,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |